Diagnostic possibilities of methods for the evaluation of liver fibrosis in chronic viral hepatitis


Cite item

Full Text

Abstract

The paper reviews the diagnostic possibilities of different methods for the evaluation of liver fibrosis in chronic viral hepatitis from the point of view of their clinical application. Histological examination retains its value as the gold standard method in evaluating the liver. Transient elastography is a rather effective tool for identifying severe liver fibrosis.

About the authors

A N Navrotsky

References

  1. Исаков В.А. Как определять выраженность фиброза печени и зачем? Клиническая гастроэнтерология и гепатология. Русское издание. 2008;1(2):72-75.
  2. Павлов Ч.С. Глушенков Д.В., Ивашкин В.Т. Современные возможности эластометрии, фибро- и акти-теста в диагностике фиброза печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2008;XVIII(4):43-52.
  3. Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol. 2005;42(1):S22-S36. doi: 10.1016/j.jhep.2004.12.008
  4. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology; 1981;1:431-435. doi: 10.1002/hep.1840010511
  5. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, Phillips M, Portmann BG, Poulsen H, Scheuer PJ, Schmid M, Thaler H. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696-699. doi: 10.1016/0168-8278(95)80226-6
  6. Desmet V. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology. 1994;19(6):1513-1520. doi: 10.1016/0270-9139(94)90250-x
  7. Scheuer P. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991;13(3):372-374. doi: 10.1016/0168-8278(91)90084-o
  8. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology. 1996;24(2):289-293. doi: 10.1002/hep.510240201
  9. Mannan R, Misra V, Misra SP, Singh PA, Dwivedi M. A Comparative Evaluation of Scoring Systems in Liver Biopsies of Patients with Chronic Viral Hepatitis. J Clin Diagn Res. 2014;8(8).FC08-FC12. doi: 10.7860/JCDR/2014/8704.4718
  10. Серов В.В., Севергина Л.О. Морфологические критерии оценки этиологии, степени активности и стадии заболевания при хронических вирусных гепатитах В и С. Архив патологии. 1996;58(4):61-64.
  11. Пинцани М. Эволюция фиброза печени: от гепатита к циррозу. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2002;XII(5):4-9.
  12. Романова Е.Б. Клинико-иммунологические и иммуногенетические аспекты фиброгенеза в печени при хроническом гепатите С: Автореф. дис. ... д-ра мед. наук. М.; 2008. Ссылка активна на 14.10.2015. Доступно по http://www.crie.ru/pdf/avtoref1%28romanova%29.pdf
  13. Goodman Z, Becker R, Pockros P, Afdhal N. Progression of fibrosis in advanced chronic hepatitis C: Evaluation by morphometric image analysis. Hepatology. 2007;45(4):886-894. doi: 10.1002/hep.21595
  14. Kweon Y, Goodman Z, Dienstag J et al. Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol. 2001;35(6):749-755. doi: 10.1016/s0168-8278(01)00218-5
  15. Afdhal N, Nunes D. Evaluation of Liver Fibrosis: A Concise Review. Am J Gastroenterol. 2004;99(6):1160-1174. doi: 10.1111/j.1572-0241.2004.30110.x
  16. Cross T, Antoniades C, Harrison P. Non-invasive markers for the prediction of fibrosis in chronic hepatitis C infection. Hepatol Res. 2008;38(8):762-769. doi: 10.1111/j.1872-034x.2008.00364.x
  17. Christiansen K, Mössner B, Hansen J, Jarnbjer E, Pedersen C, Christensen P. Liver Stiffness Measurement among Patients with Chronic Hepatitis B and C: Results from a 5-Year Prospective Study. PLoS ONE. 2014;9(11):e111912. doi: 10.1371/journal.pone.0111912
  18. Levine R, Sanderson S, Ploutz-Snyder R et al. Assessment of Fibrosis Progression in Untreated Irish Women With Chronic Hepatitis C Contracted From Immunoglobulin Anti-D. Clin Gastroenterol Hepatol. 2006;4(10):1271-1277. doi: 10.1016/j.cgh.2006.05.028
  19. Непомнящих Г.И., Айдагулова С.В., Непомнящих Д.Л., Нохрина Ж.В., Виноградова Е.В., Караваева Ю.Ю. Морфогенез хронического гепатита С и цирроза печени инфекционно-вирусного генеза. Бюллетень СО РАМН. 2008;28(6):66-77.
  20. Bani-Sadr F, Lapidus N, Bedossa P et al. Progression of Fibrosis in HIV and Hepatitis C Virus-Coinfected Patients Treated with Interferon plus Ribavirin-Based Therapy: Analysis of Risk Factors. Clin Infect Dis. 2008;46(5):768-774. doi: 10.1086/527565
  21. Sherman KE, Andersen JW, Butt AA, Umbleja T, Alston B, Koziel MJ, Peters MG, Sulkowski M, Goodman ZD. Chung R.T. Sustained Long-Term Antiviral Maintenance Therapy in HCV/HIV-Coinfected Patients (SLAM-C). JAIDS. 2010;55(5):597-605. doi: 10.1097/qai.0b013e3181f6d916
  22. Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL. Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon. New Engl J Med. 2008;359(23):2429-2441. doi: 10.1056/nejmoa0707615
  23. Ono E. Platelet count reflects stage of chronic hepatitis C. Hepatol Res. 1999;15(3):192-200. doi: 10.1016/s1386-6346(98)00075-8
  24. Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology. 2005;41(6):1376-1382. doi: 10.1002/hep.20717
  25. Carvalho-Filho RJ, Schiavon LL, Narciso-Schiavon JL, Sampaio JP, Lanzoni VP, Ferraz MLG, Silva AEB. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection. Liver Int. 2008;28(4):486-493. doi: 10.1111/j.1478-3231.2008.01675.x
  26. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, Pol S. FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection comparison with liver biopsy and fibrotest. Hepatology. 2007;46(1):32-36. doi: 10.1002/hep.21669
  27. Macías J, Girón-González JA, González-Serrano M, Merino D, Cano P, Mira JA, Arizcorreta-Yarza A, Ruíz-Morales J, Lomas-Cabeza JM, García-García JA, Corzo JE, Pineda JA. Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut. 2006;55(3):409-414. doi: 10.1136/gut.2005.065904
  28. Lok ASF, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, Everhart JE, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Dienstag JL, Morishima C. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT-C cohort. Hepatology. 2005;42(2):282-292. doi: 10.1002/hep.20772
  29. Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, Martínez-Bauer E, Bruguera M, Sánchez-Tapias JM, Rodés J. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002;36(4):986-992. doi: 10.1053/jhep.2002.36128
  30. Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y. Fibroindex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology. 2007;45(2):297-306. doi: 10.1002/hep.21520
  31. Sebastiani G, Vario A, Guido M, Alberti A. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases. J Viral Hepatitis. 2008;15(6):474-474. doi: 10.1111/j.1365-2893.2008.00987.x
  32. Leroy V, Hilleret M, Sturm N, Trocme C, Renversez J, Faure P, Morel F, Zarski J. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol. 2007;46(5):775-782. doi: 10.1016/j.jhep.2006.12.013
  33. Thabut D, Simon M, Myers RP, Messous D, Thibault V, Imbert-Bismut F, Poynard T. Noninvasive prediction of fibrosis in patients with chronic hepatitis C. Hepatology. 2003;37(5):1220-1221. doi: 10.1053/jhep.2003.50109
  34. Le Calvez S, Thabut D, Messous D, Munteanu M, Ratziu V, Imbert-Bismut F, Poynard T. The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C. Hepatology. 2004;39(3):862-863. doi: 10.1002/hep.20099
  35. Poynard T, Morra R, Halfon P, Castera L, Ratziu V, Imbert-Bismut F, Naveau S, Thabut D, Lebrec D, Zoulim F, Bourliere M, Cacoub P, Messous D, Munteanu M, de Ledinghen V. Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol. 2007;7(1):40. doi: 10.1186/1471-230x-7-40
  36. Boursier J, Bacq Y, Halfon P, Leroy V, de Ledinghen V, de Muret A, Bourlière M, Sturm N, Foucher J, Oberti F, Rousselet MC, Calès P. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol. 2009;21(1):28-38. doi: 10.1097/meg.0b013e32830cebd7
  37. Calès P, Boursier J, de Lédinghen V, Halfon P, Bacq Y, Leroy V, Dib N, Oberti F, Sawadogo A, Rousselet M, Lunel F. Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests. Gastroentérol Clin Biol. 2008;32(12):1050-1060. doi: 10.1016/j.gcb.2008.09.017
  38. Calès P, De Ledinghen V, Halfon P, Bacq Y, Leroy V, Boursier J, Foucher J, Bourlière M, De Muret A, Sturm N, Hunault G, Oberti F. Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C. Liver Int. 2008;28(10):1352-1362. doi: 10.1111/j.1478-3231.2008.01789.x
  39. Leroy V, Halfon P, Bacq Y, Boursier J, Rousselet MC, Bourlière M, de Muret A, Sturm N, Hunault G, Penaranda G, Bréchot M, Trocme C, Calès P. Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: A meta-analysis with individual data. Clin Biochem. 2008;41(16-17):1368-1376. doi: 10.1016/j.clinbiochem.2008.06.020
  40. Tural C, Tor J, Sanvisens A, Pérez-Alvarez N, Martínez E, Ojanguren I, García-Samaniego J, Rockstroh J, Barluenga E, Muga R, Planas R, Sirera G, Rey-Joly C, Clotet B. Accuracy of Simple Biochemical Tests in Identifying Liver Fibrosis in Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis C Virus. Clin Gastroenterol Hepatol. 2009;7(3):339-345. doi: 10.1016/j.cgh.2008.11.019
  41. Cacoub P, Carrat F, Bédossa P, Lambert J, Pénaranda G, Perronne C, Pol S, Halfon P. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: The fibrovic study — ANRS HC02. J Hepatol. 2008;48(5):765-773. doi: 10.1016/j.jhep.2008.01.025
  42. Bottero J, Lacombe K, Guéchot J, Serfaty L, Miailhes P, Bonnard P, Wendum D, Molina J, Lascoux-Combe C, Girard P. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients. J Hepatol. 2009;50(6):1074-1083. doi: 10.1016/j.jhep.2009.01.022
  43. Patel K, Nelson D, Rockey D, Afdhal N, Smith K, Oh E, Hettinger K, Vallée M, Dev A, Smith-Riggs M, McHutchison J. Correlation of FIBROSpect II With Histologic and Morphometric Evaluation of Liver Fibrosis in Chronic Hepatitis C. Clin Gastroenterol Hepatol. 2008;6(2):242-247. doi: 10.1016/j.cgh.2007.11.009
  44. Patel K, Gordon SC, Jacobson I, Hézode C, Oh E, Smith KM, Pawlotsky J, McHutchison JG. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol. 2004;41(6):935-942. doi: 10.1016/j.jhep.2004.08.008
  45. Patel K, Benhamou Y, Yoshida EM, Kaita KD, Zeuzem S, Torbenson M, Pulkstenis E, Subramanian GM, McHutchison JG. An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBRO Spect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C. J Viral Hepatitis. 2009;16(3):178-186. doi: 10.1111/j.1365-2893.2008.01062.x
  46. Кузнецова А.В., Жердева А.И., Горовенко Н.А., Дуботолкина Е.В., Лойфман Е.А. Место и роль серологических маркеров фиброза в диагностике и лечении хронической HCV-инфекции. Клинические перспективы гастроэнтерологии, гепатологии. 2007;3:35-39.
  47. Halfon P, Bourlière M, Pénaranda G, Deydier R, Renou C, Botta-Fridlund D, Tran A, Portal I, Allemand I, Rosenthal-Allieri A, Ouzan D. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp Hepatol. 2005;4:6. doi: 10.1186/1476-5926-4-6
  48. Montazeri G, Estakhri A, Mohamadnejad M, Nouri N, Montazeri F, Mohammadkani A, Derakhshan MH, Zamani F, Samiee S, Malekzadeh R. Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B. BMC Gastroenterology. 2005;5:32. doi: 10.1186/1471-230X-5-32
  49. White IR, Patel K, Symonds WT, Dev A, Griffin P, Tsokanas N, Skehel M, Liu C, Zekry A, Cutler P, Gattu M, Rockey DC, Berrey M, McHutchison JG. Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection. J Translational Med. 2007;5(1):33. doi: 10.1186/1479-5876-5-33
  50. Romagnuolo J. Predicting the liver histology in chronic hepatitis C: how good is the clinician? Am J Gastroenterol. 2001;96(11):3165-3174. doi: 10.1016/s0002-9270(01)03837-0
  51. Castera L. Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C. Gastroenterology. 2012;142(6):1293-1302.e4. doi: 10.1053/j.gastro.2012.02.017
  52. Degos F, Perez P, Asselineau J, Bedossa P. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study). J Hepatol. 2011;55(1):234-235. doi: 10.1016/j.jhep.2011.01.015
  53. Talwalkar J, Kurtz D, Schoenleber S, West C, Montori V. Ultrasound-Based Transient Elastography for the Detection of Hepatic Fibrosis: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2007;5(10):1214-1220. doi: 10.1016/j.cgh.2007.07.020
  54. Дудина К., Знойко О., Шутько С., Козина А., Ющук Н. Сравнительный анализ инвазивной и неинвазивной диагностики фиброза печени у больных ХГВ. Врач. 2011;(10):57-59.
  55. Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, Hassanein T, Asbach P, Godfrey EM, Yin M, Chen J, Keaveny AP, Bridges M, Bohte A, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL. Diagnostic Performance of Magnetic Resonance Elastography in Staging Liver Fibrosis: A Systematic Review and Meta-analysis of Individual Participant Data. Clin Gastroenterol Hepatol. 2015;13(3):440-451.e6. doi: 10.1016/j.cgh.2014.09.046
  56. Yin M, Talwalkar JA, Glaser KJ, Manduca A, Grimm RC, Rossman PJ, Fidler JL, Ehman RL. Оценка выраженности фиброза печени с помощью магнитно-резонансной эластографии. Клиническая гастроэнтерология и гепатология. Русское издание. 2008;1(2):92-100.
  57. Lewin M, Poujol-Robert A, Boëlle P, Wendum D, Lasnier E, Viallon M, Guéchot J, Hoeffel C, Arrivé L, Tubiana J, Poupon R. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology. 2007;46(3):658-665. doi: 10.1002/hep.21747
  58. Раевнева Т.Г. Визуализационные методы в диагностике стадии фиброза при хронических диффузных заболеваниях печени. Здравоохранение. 2012;(5):31-33.
  59. Giannini EG, Fasoli A, Borro P, Botta F, Malfatti F, Fumagalli A, Testa E, Polegato S, Cotellessa T, Milazzo S, Risso D, Testa R. Применение экспираторных проб с С-галактозой и С-аминопирином для оценки функции печени при хронических заболеваниях печени. Клиническая гастроэнтерология и гепатология. Русское издание. 2008;1(2):110-116.
  60. Ивкова А.Н., Ильченко Л.Ю., Кушлинский Н.Е., Сторожаков Г.И. Содержание ростовых факторов в сыворотке крови пациентов с хроническим гепатитом С и С-индуцированным циррозом печени. Мир вирусных гепатитов. 2008;10(2):5-8. Ссылка активна на 14.10.2015. Доступно по http://astro-sirius.ru/hi0208/hi0208.pdf

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies